"alpha-Synuclein/genetics"[MAJR] - Search Results

Year	Number of Results
2004	3
2005	17
2006	42
2007	45
2008	58
2009	41
2010	57
2011	66
2012	60
2013	75
2014	83
2015	78
2016	76
2017	84
2018	90
2019	70
2020	90
2021	87
2022	97
2023	61
2024	19

1

The Parkinson's disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability.

Hallacli E, Kayatekin C, Nazeen S, Wang XH, Sheinkopf Z, Sathyakumar S, Sarkar S, Jiang X, Dong X, Di Maio R, Wang W, Keeney MT, Felsky D, Sandoe J, Vahdatshoar A, Udeshi ND, Mani DR, Carr SA, Lindquist S, De Jager PL, Bartel DP, Myers CL, Greenamyre JT, Feany MB, Sunyaev SR, Chung CY, Khurana V. Hallacli E, et al. Cell. 2022 Jun 9;185(12):2035-2056.e33. doi: 10.1016/j.cell.2022.05.008. Cell. 2022. PMID: 35688132 Free PMC article.

2

α-synuclein seed amplification in Parkinson's disease.

Beach TG, Adler CH, Shill HA, Serrano GE, Zhang N. Beach TG, et al. Lancet Neurol. 2023 Nov;22(11):985. doi: 10.1016/S1474-4422(23)00373-3. Lancet Neurol. 2023. PMID: 37863604 No abstract available.

3

α-synuclein seed amplification and its uses in Parkinson's disease.

Berg D, Klein C. Berg D, et al. Lancet Neurol. 2023 May;22(5):369-371. doi: 10.1016/S1474-4422(23)00124-2. Lancet Neurol. 2023. PMID: 37059498 No abstract available.

4

Roles for α-Synuclein in Gene Expression.

Somayaji M, Lanseur Z, Choi SJ, Sulzer D, Mosharov EV. Somayaji M, et al. Genes (Basel). 2021 Jul 29;12(8):1166. doi: 10.3390/genes12081166. Genes (Basel). 2021. PMID: 34440340 Free PMC article. Review.

5

Mutations in α-synuclein, TDP-43 and tau prolong protein half-life through diminished degradation by lysosomal proteases.

Sampognaro PJ, Arya S, Knudsen GM, Gunderson EL, Sandoval-Perez A, Hodul M, Bowles K, Craik CS, Jacobson MP, Kao AW. Sampognaro PJ, et al. Mol Neurodegener. 2023 May 2;18(1):29. doi: 10.1186/s13024-023-00621-8. Mol Neurodegener. 2023. PMID: 37131250 Free PMC article.

6

Alpha-synuclein and the prion hypothesis in Parkinson's disease.

Melki R. Melki R. Rev Neurol (Paris). 2018 Nov;174(9):644-652. doi: 10.1016/j.neurol.2018.08.002. Epub 2018 Sep 7. Rev Neurol (Paris). 2018. PMID: 30201422 Review.

7

Interaction of alpha-synuclein with lipids.

Kachappilly N, Srivastava J, Swain BP, Thakur P. Kachappilly N, et al. Methods Cell Biol. 2022;169:43-66. doi: 10.1016/bs.mcb.2021.12.002. Epub 2022 Feb 24. Methods Cell Biol. 2022. PMID: 35623711

8

Microglial LRRK2-mediated NFATc1 attenuates α-synuclein immunotoxicity in association with CX3CR1-induced migration and the lysosome-initiated degradation.

Feng L, Lo H, Hong Z, Zheng J, Yan Y, Ye Z, Chen X, Pan X. Feng L, et al. Glia. 2023 Sep;71(9):2266-2284. doi: 10.1002/glia.24422. Epub 2023 Jun 10. Glia. 2023. PMID: 37300531

9

α-Synuclein and Parkinsonism: Updates and Future Perspectives.

Rosborough K, Patel N, Kalia LV. Rosborough K, et al. Curr Neurol Neurosci Rep. 2017 Apr;17(4):31. doi: 10.1007/s11910-017-0737-y. Curr Neurol Neurosci Rep. 2017. PMID: 28324300 Review.

10

α-Synuclein nonhuman primate models of Parkinson's disease.

Marmion DJ, Kordower JH. Marmion DJ, et al. J Neural Transm (Vienna). 2018 Mar;125(3):385-400. doi: 10.1007/s00702-017-1720-0. Epub 2017 Apr 22. J Neural Transm (Vienna). 2018. PMID: 28434076 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

1,123 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

1,123 results

Results by year